Impressions of this year's European HealthTech CEO Forum (EHTF) with 4D Lifetec

As a pioneer in the field of non-genomic immuno-oncological blood tests for the early detection of cancer, 4D Lifetec AG has been at the center of attention in the debate on personalized medicine and diagnostics.

One of the ostensible topics of discussion was the benefits and potential of blood-based cancer screening tests. These tests offer various opportunities for players across the diagnostic and clinical value chain to create significant clinical and commercial value. In this context, the added value for the patient is paramount and crucial.

Through the 4D Lifetest™, 4D Lifetec offers a breakthrough key element in the diagnostic cascade for major cancer types by adding high early detection sensitivity.